Latest News and Press Releases
Want to stay updated on the latest news?
-
COLORADO SPRINGS, Colo., Aug. 10, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”), a developer and manufacturer of single-use medical devices used in minimally...
-
COLORADO SPRINGS, Colo., Aug. 03, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today reported financial results for the three months ended June 30, 2017....
-
COLORADO SPRINGS, Colo., July 26, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) of...
-
COLORADO SPRINGS, Colo., July 13, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today announced that it will release financial results for the second quarter...
-
Highly complementary addition to Philips’ Image-Guided Therapy Business Group, strengthening its position in EUR 6+ billion marketSpectranetics’ strong device portfolio for vascular intervention and...
-
COLORADO SPRINGS, Colo., June 14, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) announced today that B. Kristine Johnson has been elected as the new...
-
COLORADO SPRINGS, Colo., June 09, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) announced today that it has amended its existing credit facilities led by...
-
COLORADO SPRINGS, Colo., April 27, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today reported financial results for the three months ended March 31,...
-
COLORADO SPRINGS, Colo., April 07, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), today announced that the Company will release first quarter 2017 financial results on...
-
COLORADO SPRINGS, Colo., Feb. 23, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months and year ended December 31,...